Fixed dose combination and single administration analysis [General Sta­tis­tics]

posted by BRN – Turkey, 2015-07-16 13:23 (3529 d 22:39 ago) – Posting: # 15094
Views: 4,808

Hi John, thank you for your reply.

❝ I don't understand your reasons for #2 and #3.


Actually the study is a 4 period study. The aim is to compare T and R in terms of BE, additionally to investigate drug interactions at the same time since there is no FDC as reference. That's why investigating the BE as 2 period study makes sence to me as well, however I've seen examples such as #2 and #3, that's why trying to make sure which is the best approach.

Regards,
BRN

Complete thread:

UA Flag
Activity
 Admin contact
23,408 posts in 4,920 threads, 1,665 registered users;
28 visitors (1 registered, 27 guests [including 9 identified bots]).
Forum time: 11:03 CET (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5